Historical record - last NADAC publication: 5/22/2019
Product Information
TERBINAFINE HCL 250 MG TABLET is a generic product labeled by Exelan Pharmaceuticals Inc., priced at $0.1761 per EA under NDC 76282020930. Its NADAC has been published 287 times since Nov 28, 2013.
Strength
250 mg/1
Manufacturer
Exelan Pharmaceuticals Inc.NDC
76282020930
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
5/22/2019
Active Ingredients
TERBINAFINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA077533On Market Since
4/25/2012
Pharmacological Classes
Price Statistics
The NADAC for TERBINAFINE HCL 250 MG TABLET has been published 287 times since Nov 28, 2013, and over the history we have for it it has risen 12.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1761 per EA |
|---|---|
| All-time high | $0.1869 (Apr 16, 2014) |
| All-time low | $0.1332 (Oct 21, 2015) |
| Median price | $0.1548 |
| Average price | $0.1573 |
| Largest weekly change | -21.3% (Aug 19, 2015) |
| Weeks tracked | 287 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 24% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TERBINAFINE HCL 250 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TERBINAFINE HCL 250 MG TABLET, manufactured by Exelan Pharmaceuticals Inc., is $0.1761 per EA (NDC 76282020930), effective May 22, 2019.
How has the price of TERBINAFINE HCL 250 MG TABLET changed over time?
Over the history we have for it, the NADAC for TERBINAFINE HCL 250 MG TABLET has risen 12.6%. It has been tracked across 287 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for TERBINAFINE HCL 250 MG TABLET?
Since Nov 28, 2013, the NADAC for TERBINAFINE HCL 250 MG TABLET has ranged from a low of $0.1332 (Oct 21, 2015) to a high of $0.1869 (Apr 16, 2014), with a median of $0.1548 per EA.
Are there cheaper alternatives to TERBINAFINE HCL 250 MG TABLET?
Yes. 2 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, TERBINAFINE HCL 250 MG TABLET, is $0.1341 per EA — about 24% below TERBINAFINE HCL 250 MG TABLET.
Who manufactures TERBINAFINE HCL 250 MG TABLET?
TERBINAFINE HCL 250 MG TABLET (NDC 76282020930) is labeled by Exelan Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification